Table of Contents 1 Oncology Based Molecular Diagnostics Market Overview 1.1 Product Overview and Scope of Oncology Based Molecular Diagnostics 1.2 Oncology Based Molecular Diagnostics Segment by Type 1.2.1 Global Oncology Based Molecular Diagnostics Production Growth Rate Comparison by Type 2020 VS 2026 1.2.2 PCR 1.2.3 Multiplex PCR 1.2.4 In Situ Hybridization 1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT) 1.3 Oncology Based Molecular Diagnostics Segment by Application 1.3.1 Oncology Based Molecular Diagnostics Consumption Comparison by Application: 2020 VS 2026 1.3.2 Breast Cancer 1.3.3 Prostate Cancer 1.3.4 Colorectal Cancer 1.3.5 Cervical Cancer 1.3.6 Other 1.4 Global Oncology Based Molecular Diagnostics Market by Region 1.4.1 Global Oncology Based Molecular Diagnostics Market Size Estimates and Forecasts by Region: 2020 VS 2026 1.4.2 North America Estimates and Forecasts (2015-2026) 1.4.3 Europe Estimates and Forecasts (2015-2026) 1.4.4 China Estimates and Forecasts (2015-2026) 1.4.5 Japan Estimates and Forecasts (2015-2026) 1.5 Global Oncology Based Molecular Diagnostics Growth Prospects 1.5.1 Global Oncology Based Molecular Diagnostics Revenue Estimates and Forecasts (2015-2026) 1.5.2 Global Oncology Based Molecular Diagnostics Production Capacity Estimates and Forecasts (2015-2026) 1.5.3 Global Oncology Based Molecular Diagnostics Production Estimates and Forecasts (2015-2026) 2 Market Competition by Manufacturers 2.1 Global Oncology Based Molecular Diagnostics Production Capacity Market Share by Manufacturers (2015-2020) 2.2 Global Oncology Based Molecular Diagnostics Revenue Share by Manufacturers (2015-2020) 2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.4 Global Oncology Based Molecular Diagnostics Average Price by Manufacturers (2015-2020) 2.5 Manufacturers Oncology Based Molecular Diagnostics Production Sites, Area Served, Product Types 2.6 Oncology Based Molecular Diagnostics Market Competitive Situation and Trends 2.6.1 Oncology Based Molecular Diagnostics Market Concentration Rate 2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue 2.6.3 Mergers & Acquisitions, Expansion 3 Production Capacity by Region 3.1 Global Production Capacity of Oncology Based Molecular Diagnostics Market Share by Regions (2015-2020) 3.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Regions (2015-2020) 3.3 Global Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 North America Oncology Based Molecular Diagnostics Production 3.4.1 North America Oncology Based Molecular Diagnostics Production Growth Rate (2015-2020) 3.4.2 North America Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Europe Oncology Based Molecular Diagnostics Production 3.5.1 Europe Oncology Based Molecular Diagnostics Production Growth Rate (2015-2020) 3.5.2 Europe Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 China Oncology Based Molecular Diagnostics Production 3.6.1 China Oncology Based Molecular Diagnostics Production Growth Rate (2015-2020) 3.6.2 China Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Japan Oncology Based Molecular Diagnostics Production 3.7.1 Japan Oncology Based Molecular Diagnostics Production Growth Rate (2015-2020) 3.7.2 Japan Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Oncology Based Molecular Diagnostics Consumption by Regions 4.1 Global Oncology Based Molecular Diagnostics Consumption by Regions 4.1.1 Global Oncology Based Molecular Diagnostics Consumption by Region 4.1.2 Global Oncology Based Molecular Diagnostics Consumption Market Share by Region 4.2 North America 4.2.1 North America Oncology Based Molecular Diagnostics Consumption by Countries 4.2.2 U.S. 4.2.3 Canada 4.3 Europe 4.3.1 Europe Oncology Based Molecular Diagnostics Consumption by Countries 4.3.2 Germany 4.3.3 France 4.3.4 U.K. 4.3.5 Italy 4.3.6 Russia 4.4 Asia Pacific 4.4.1 Asia Pacific Oncology Based Molecular Diagnostics Consumption by Region 4.4.2 China 4.4.3 Japan 4.4.4 South Korea 4.4.5 Taiwan 4.4.6 Southeast Asia 4.4.7 India 4.4.8 Australia 4.5 Latin America 4.5.1 Latin America Oncology Based Molecular Diagnostics Consumption by Countries 4.5.2 Mexico 4.5.3 Brazil 5 Production, Revenue, Price Trend by Type 5.1 Global Oncology Based Molecular Diagnostics Production Market Share by Type (2015-2020) 5.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2015-2020) 5.3 Global Oncology Based Molecular Diagnostics Price by Type (2015-2020) 5.4 Global Oncology Based Molecular Diagnostics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 6 Global Oncology Based Molecular Diagnostics Market Analysis by Application 6.1 Global Oncology Based Molecular Diagnostics Consumption Market Share by Application (2015-2020) 6.2 Global Oncology Based Molecular Diagnostics Consumption Growth Rate by Application (2015-2020) 7 Company Profiles and Key Figures in Oncology Based Molecular Diagnostics Business 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Oncology Based Molecular Diagnostics Production Sites and Area Served 7.1.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.1.4 Main Business and Markets Served 7.2 Bayer Healthcare 7.2.1 Bayer Healthcare Oncology Based Molecular Diagnostics Production Sites and Area Served 7.2.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.2.4 Main Business and Markets Served 7.3 Becton Dickinson 7.3.1 Becton Dickinson Oncology Based Molecular Diagnostics Production Sites and Area Served 7.3.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.3.4 Main Business and Markets Served 7.4 Cepheid 7.4.1 Cepheid Oncology Based Molecular Diagnostics Production Sites and Area Served 7.4.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.4.3 Cepheid Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.4.4 Main Business and Markets Served 7.5 Dako 7.5.1 Dako Oncology Based Molecular Diagnostics Production Sites and Area Served 7.5.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.5.3 Dako Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.5.4 Main Business and Markets Served 7.6 Danaher Corporation 7.6.1 Danaher Corporation Oncology Based Molecular Diagnostics Production Sites and Area Served 7.6.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.6.4 Main Business and Markets Served 7.7 Gen Probe(Hologic) 7.7.1 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Production Sites and Area Served 7.7.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.4.4 Main Business and Markets Served 7.8 Roche Diagnostics 7.8.1 Roche Diagnostics Oncology Based Molecular Diagnostics Production Sites and Area Served 7.8.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.8.4 Main Business and Markets Served 7.9 Siemens Healthcare 7.9.1 Siemens Healthcare Oncology Based Molecular Diagnostics Production Sites and Area Served 7.9.2 Oncology Based Molecular Diagnostics Product Introduction, Application and Specification 7.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020) 7.9.4 Main Business and Markets Served 8 Oncology Based Molecular Diagnostics Manufacturing Cost Analysis 8.1 Oncology Based Molecular Diagnostics Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Raw Materials Price Trend 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Oncology Based Molecular Diagnostics 8.4 Oncology Based Molecular Diagnostics Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.2 Oncology Based Molecular Diagnostics Distributors List 9.3 Oncology Based Molecular Diagnostics Customers 10 Market Dynamics 10.1 Market Trends 10.2 Opportunities and Drivers 10.3 Challenges 10.4 Porter's Five Forces Analysis 11 Production and Supply Forecast 11.1 Global Forecasted Production of Oncology Based Molecular Diagnostics (2021-2026) 11.2 Global Forecasted Revenue of Oncology Based Molecular Diagnostics (2021-2026) 11.3 Global Forecasted Price of Oncology Based Molecular Diagnostics (2021-2026) 11.4 Global Oncology Based Molecular Diagnostics Production Forecast by Regions (2021-2026) 11.4.1 North America Oncology Based Molecular Diagnostics Production, Revenue Forecast (2021-2026) 11.4.2 Europe Oncology Based Molecular Diagnostics Production, Revenue Forecast (2021-2026) 11.4.3 China Oncology Based Molecular Diagnostics Production, Revenue Forecast (2021-2026) 11.4.4 Japan Oncology Based Molecular Diagnostics Production, Revenue Forecast (2021-2026) 12 Consumption and Demand Fprecast 12.1 Global Forecasted and Consumption Demand Analysis of Oncology Based Molecular Diagnostics 12.2 North America Forecasted Consumption of Oncology Based Molecular Diagnostics by Country 12.3 Europe Market Forecasted Consumption of Oncology Based Molecular Diagnostics by Country 12.4 Asia Pacific Market Forecasted Consumption of Oncology Based Molecular Diagnostics by Regions 12.5 Latin America Forecasted Consumption of Oncology Based Molecular Diagnostics 13 Forecast by Type and by Application (2021-2026) 13.1 Global Production, Revenue and Price Forecast by Type (2021-2026) 13.1.1 Global Forecasted Production of Oncology Based Molecular Diagnostics by Type (2021-2026) 13.1.2 Global Forecasted Revenue of Oncology Based Molecular Diagnostics by Type (2021-2026) 13.1.2 Global Forecasted Price of Oncology Based Molecular Diagnostics by Type (2021-2026) 13.2 Global Forecasted Consumption of Oncology Based Molecular Diagnostics by Application (2021-2026) 14 Reseach Finding and Conclusion 15 Methodology and Data Source 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Author List 15.4 Disclaimer

List of Tables Table 1. Global Oncology Based Molecular Diagnostics Production (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Oncology Based Molecular Diagnostics Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 3. Global Oncology Based Molecular Diagnostics Consumption (K Units) Comparison by Application: 2020 VS 2026 Table 4. Global Oncology Based Molecular Diagnostics Production (K Units) by Manufacturers Table 5. Global Oncology Based Molecular Diagnostics Production (K Units) by Manufacturers (2015-2020) Table 6. Global Oncology Based Molecular Diagnostics Production Share by Manufacturers (2015-2020) Table 7. Global Oncology Based Molecular Diagnostics Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Oncology Based Molecular Diagnostics Revenue Share by Manufacturers (2015-2020) Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based Molecular Diagnostics as of 2019) Table 10. Global Market Oncology Based Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 11. Manufacturers Oncology Based Molecular Diagnostics Production Sites and Area Served Table 12. Manufacturers Oncology Based Molecular Diagnostics Product Types Table 13. Global Oncology Based Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14.Mergers & Acquisitions, Expansion Table 15. Global Oncology Based Molecular Diagnostics Capacity (K Units) by Region (2015-2020) Table 16. Global Oncology Based Molecular Diagnostics Production (K Units) by Region (2015-2020) Table 17. Global Oncology Based Molecular Diagnostics Revenue (Million US$) by Region (2015-2020) Table 18. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2015-2020) Table 19. Global Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 20. North America Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 21. Europe Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 22. China Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 23. Japan Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 24. Global Oncology Based Molecular Diagnostics Consumption (K Units) Market by Region (2015-2020) Table 25. Global Oncology Based Molecular Diagnostics Consumption Market Share by Region (2015-2020) Table 26. North America Oncology Based Molecular Diagnostics Consumption by Countries (2015-2020) (K Units) Table 27. Europe Oncology Based Molecular Diagnostics Consumption by Countries (2015-2020) (K Units) Table 28. Asia Pacific Oncology Based Molecular Diagnostics Consumption by Countries (2015-2020) (K Units) Table 29. Latin America Oncology Based Molecular Diagnostics Consumption by Countries (2015-2020) (K Units) Table 30. Global Oncology Based Molecular Diagnostics Production (K Units) by Type (2015-2020) Table 31. Global Oncology Based Molecular Diagnostics Production Share by Type (2015-2020) Table 32. Global Oncology Based Molecular Diagnostics Revenue (Million US$) by Type (2015-2020) Table 33. Global Oncology Based Molecular Diagnostics Revenue Share by Type (2015-2020) Table 34. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Type (2015-2020) Table 35. Global Oncology Based Molecular Diagnostics Consumption (K Units) by Application (2015-2020) Table 36. Global Oncology Based Molecular Diagnostics Consumption Market Share by Application (2015-2020) Table 37. Global Oncology Based Molecular Diagnostics Consumption Growth Rate by Application (2015-2020) Table 38. Abbott Laboratories Oncology Based Molecular Diagnostics Production Sites and Area Served Table 39. Abbott Laboratories Production Sites and Area Served Table 40. Abbott Laboratories Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 41. Abbott Laboratories Main Business and Markets Served Table 42. Bayer Healthcare Oncology Based Molecular Diagnostics Production Sites and Area Served Table 43. Bayer Healthcare Production Sites and Area Served Table 44. Bayer Healthcare Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 45. Bayer Healthcare Main Business and Markets Served Table 46. Becton Dickinson Oncology Based Molecular Diagnostics Production Sites and Area Served Table 47. Becton Dickinson Production Sites and Area Served Table 48. Becton Dickinson Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 49. Becton Dickinson Main Business and Markets Served Table 50. Cepheid Oncology Based Molecular Diagnostics Production Sites and Area Served Table 51. Cepheid Production Sites and Area Served Table 52. Cepheid Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 53. Cepheid Main Business and Markets Served Table 54. Dako Oncology Based Molecular Diagnostics Production Sites and Area Served Table 55. Dako Production Sites and Area Served Table 56. Dako Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 57. Dako Main Business and Markets Served Table 58. Danaher Corporation Oncology Based Molecular Diagnostics Production Sites and Area Served Table 59. Danaher Corporation Production Sites and Area Served Table 60. Danaher Corporation Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Danaher Corporation Main Business and Markets Served Table 62. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Production Sites and Area Served Table 63. Gen Probe(Hologic) Production Sites and Area Served Table 64. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 65. Gen Probe(Hologic) Main Business and Markets Served Table 66. Roche Diagnostics Oncology Based Molecular Diagnostics Production Sites and Area Served Table 67. Roche Diagnostics Production Sites and Area Served Table 68. Roche Diagnostics Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 69. Roche Diagnostics Main Business and Markets Served Table 70. Siemens Healthcare Oncology Based Molecular Diagnostics Production Sites and Area Served Table 71. Siemens Healthcare Production Sites and Area Served Table 72. Siemens Healthcare Oncology Based Molecular Diagnostics Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 73. Siemens Healthcare Main Business and Markets Served Table 74. Production Base and Market Concentration Rate of Raw Material Table 75. Key Suppliers of Raw Materials Table 76. Oncology Based Molecular Diagnostics Distributors List Table 77. Oncology Based Molecular Diagnostics Customers List Table 78. Market Key Trends Table 79. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 80. Key Challenges Table 81. Global Oncology Based Molecular Diagnostics Production (K Units) Forecast by Region (2021-2026) Table 82. North America Oncology Based Molecular Diagnostics Consumption Forecast 2021-2026 (K Units) by Country Table 83. Europe Oncology Based Molecular Diagnostics Consumption Forecast 2021-2026 (K Units) by Country Table 84. Asia Pacific Oncology Based Molecular Diagnostics Consumption Forecast 2021-2026 (K Units) by Regions Table 85. Latin America Oncology Based Molecular Diagnostics Consumption Forecast 2021-2026 (K Units) by Country Table 86. Global Oncology Based Molecular Diagnostics Consumption (K Units) Forecast by Regions (2021-2026) Table 87. Global Oncology Based Molecular Diagnostics Production (K Units) Forecast by Type (2021-2026) Table 88. Global Oncology Based Molecular Diagnostics Revenue (Million US$) Forecast by Type (2021-2026) Table 89. Global Oncology Based Molecular Diagnostics Price (USD/Unit) Forecast by Type (2021-2026) Table 90. Global Oncology Based Molecular Diagnostics Consumption (K Units) Forecast by Application (2021-2026) Table 91.Research Programs/Design for This Report Table 92.Key Data Information from Secondary Sources Table 93.Key Data Information from Primary Sources List of Figures Figure 1. Picture of Oncology Based Molecular Diagnostics Figure 2. Global Oncology Based Molecular Diagnostics Production Market Share by Type: 2020 VS 2026 Figure 3. PCR Product Picture Figure 4. Multiplex PCR Product Picture Figure 5. In Situ Hybridization Product Picture Figure 6. Isothermal Nucleic Acid Amplification Technology (INAAT) Product Picture Figure 7. Global Oncology Based Molecular Diagnostics Consumption Market Share by Application: 2020 VS 2026 Figure 8. Breast Cancer Figure 9. Prostate Cancer Figure 10. Colorectal Cancer Figure 11. Cervical Cancer Figure 12. Other Figure 13. North America Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate (2015-2026) Figure 14. Europe Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate (2015-2026) Figure 15. China Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate (2015-2026) Figure 16. Japan Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate (2015-2026) Figure 17. Global Oncology Based Molecular Diagnostics Revenue (Million US$) (2015-2026) Figure 18. Global Oncology Based Molecular Diagnostics Production Capacity (K Units) (2015-2026) Figure 19. Oncology Based Molecular Diagnostics Production Share by Manufacturers in 2019 Figure 20. Global Oncology Based Molecular Diagnostics Revenue Share by Manufacturers in 2019 Figure 21. Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Market Oncology Based Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2019 Figure 23. The Global 5 and 10 Largest Players: Market Share by Oncology Based Molecular Diagnostics Revenue in 2019 Figure 24. Global Oncology Based Molecular Diagnostics Production Market Share by Region (2015-2020) Figure 25. Global Oncology Based Molecular Diagnostics Production Market Share by Region in 2019 Figure 26. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2015-2020) Figure 27. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region in 2019 Figure 28. Global Oncology Based Molecular Diagnostics Production (K Units) Growth Rate (2015-2020) Figure 29. North America Oncology Based Molecular Diagnostics Production (K Units) Growth Rate (2015-2020) Figure 30. Europe Oncology Based Molecular Diagnostics Production (K Units) Growth Rate (2015-2020) Figure 31. China Oncology Based Molecular Diagnostics Production (K Units) Growth Rate (2015-2020) Figure 32. Japan Oncology Based Molecular Diagnostics Production (K Units) Growth Rate (2015-2020) Figure 33. Global Oncology Based Molecular Diagnostics Consumption Market Share by Region (2015-2020) Figure 34. Global Oncology Based Molecular Diagnostics Consumption Market Share by Region in 2019 Figure 35. North America Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 36. North America Oncology Based Molecular Diagnostics Consumption Market Share by Countries in 2019 Figure 37. Canada Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 38. U.S. Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 39. Europe Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 40. Europe Oncology Based Molecular Diagnostics Consumption Market Share by Countries in 2019 Figure 41. Germany America Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 42. France Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 43. U.K. Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 44. Italy Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 45. Russia Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 46. Asia Pacific Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 47. Asia Pacific Oncology Based Molecular Diagnostics Consumption Market Share by Regions in 2019 Figure 48. China Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 49. Japan Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 50. South Korea Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 51. Taiwan Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 52. Southeast Asia Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 53. India Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 54. Australia Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 55. Latin America Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 56. Latin America Oncology Based Molecular Diagnostics Consumption Market Share by Countries in 2019 Figure 57. Mexico Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 58. Brazil Oncology Based Molecular Diagnostics Consumption Growth Rate (2015-2020) (K Units) Figure 59. Production Market Share of Oncology Based Molecular Diagnostics by Type (2015-2020) Figure 60. Production Market Share of Oncology Based Molecular Diagnostics by Type in 2019 Figure 61. Revenue Share of Oncology Based Molecular Diagnostics by Type (2015-2020) Figure 62. Revenue Market Share of Oncology Based Molecular Diagnostics by Type in 2019 Figure 63. Global Oncology Based Molecular Diagnostics Production Growth by Type (2015-2020) (K Units) Figure 64. Global Oncology Based Molecular Diagnostics Consumption Market Share by Application (2015-2020) Figure 65. Global Oncology Based Molecular Diagnostics Consumption Market Share by Application in 2019 Figure 66. Global Oncology Based Molecular Diagnostics Consumption Growth Rate by Application (2015-2020) Figure 67. Price Trend of Key Raw Materials Figure 68. Manufacturing Cost Structure of Oncology Based Molecular Diagnostics Figure 69. Manufacturing Process Analysis of Oncology Based Molecular Diagnostics Figure 70. Oncology Based Molecular Diagnostics Industrial Chain Analysis Figure 71. Channels of Distribution Figure 72. Distributors Profiles Figure 73. Porter's Five Forces Analysis Figure 74. Global Oncology Based Molecular Diagnostics Production Capacity (K Units) and Growth Rate Forecast (2021-2026) Figure 75. Global Oncology Based Molecular Diagnostics Production (K Units) and Growth Rate Forecast (2021-2026) Figure 76. Global Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 77. Global Oncology Based Molecular Diagnostics Price and Trend Forecast (2021-2026) Figure 78. Global Oncology Based Molecular Diagnostics Production Market Share Forecast by Region (2021-2026) Figure 79. North America Oncology Based Molecular Diagnostics Production (K Units) and Growth Rate Forecast (2021-2026) Figure 80. North America Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 81. Europe Oncology Based Molecular Diagnostics Production (K Units) and Growth Rate Forecast (2021-2026) Figure 82. Europe Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 83. China Oncology Based Molecular Diagnostics Production (K Units) and Growth Rate Forecast (2021-2026) Figure 84. China Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 85. Japan Oncology Based Molecular Diagnostics Production (K Units) and Growth Rate Forecast (2021-2026) Figure 86. Japan Oncology Based Molecular Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 87. Global Forecasted and Consumption Demand Analysis of Oncology Based Molecular Diagnostics Figure 88. North America Oncology Based Molecular Diagnostics Consumption (K Units) Growth Rate Forecast (2021-2026) Figure 89. Europe Oncology Based Molecular Diagnostics Consumption (K Units) Growth Rate Forecast (2021-2026) Figure 90. Asia Pacific Oncology Based Molecular Diagnostics Consumption (K Units) Growth Rate Forecast (2021-2026) Figure 91. Latin America Oncology Based Molecular Diagnostics Consumption (K Units) Growth Rate Forecast (2021-2026) Figure 92. Global Oncology Based Molecular Diagnostics Production (K Units) Forecast by Type (2021-2026) Figure 93. Global Oncology Based Molecular Diagnostics Revenue Market Share Forecast by Type (2021-2026) Figure 94. Global Oncology Based Molecular Diagnostics Consumption Forecast by Application (2021-2026) Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation

Abbott Laboratories Bayer Healthcare Becton Dickinson Cepheid Dako Danaher Corporation Gen Probe(Hologic) Roche Diagnostics Siemens Healthcare